Taysha Gene Therapies, Inc. (TSHA)

NASDAQ: TSHA · Real-Time Price · USD

1.440

-0.090 (-5.88%)

Nov 4, 2024, 12:54 PM EST - Market open

Taysha Gene Therapies Employees

Taysha Gene Therapies had 52 employees as of December 31, 2023. The number of employees decreased by 13 or -20.00% compared to the previous year.

Employees

52

Change (1Y)

-13

Growth (1Y)

-20.00%

Revenue / Employee

$247,558

Profits / Employee

-$2,198,750

Market Cap

295.12M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	52	-13	-20.00%
Dec 31, 2022	65	-113	-63.48%
Dec 31, 2021	178	140	368.42%
Dec 31, 2020	38	-	-

Related Stocks

Company Name	Employees
Aurora Cannabis	1,073
OraSure Technologies	638
Treace Medical Concepts	516
Spok Holdings	384
Jin Medical International	245
AC Immune	161
Rezolute	51
Jasper Therapeutics	45

Employee Rankings

TSHA News

2 days ago - Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
13 days ago - Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress - GlobeNewsWire
21 days ago - Taysha Gene Therapies: Unjustified Sell-Off - Enough Cash Runway And Promising Rett Syndrome Data - Seeking Alpha
3 months ago - Taysha Gene Therapies, Inc. (TSHA) Q2 2024 Earnings Call Transcript - Seeking Alpha
3 months ago - Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
4 months ago - Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
4 months ago - Worthington Enterprises Posts Downbeat Results, Joins Taysha Gene Therapies, General Mills And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
4 months ago - Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire